Index RUT
P/E -
EPS (ttm) -0.13
Insider Own 1.10%
Shs Outstand 50.77M
Perf Week 1.03%
Market Cap 3.52B
Forward P/E 96.87
EPS next Y 0.71
Insider Trans -16.90%
Shs Float 50.44M
Perf Month 0.74%
Income -6.09M
PEG -
EPS next Q -0.05
Inst Own 100.91%
Short Float 5.84%
Perf Quarter 9.60%
Sales 366.38M
P/S 9.60
EPS this Y 399.12%
Inst Trans 3.14%
Short Ratio 2.21
Perf Half Y 23.51%
Book/sh 12.56
P/B 5.49
EPS next Y 98.36%
ROA -0.88%
Short Interest 2.94M
Perf Year 25.67%
Cash/sh 6.76
P/C 10.20
EPS next 5Y -
ROE -1.01%
52W Range 47.59 - 69.68
Perf YTD 10.83%
Dividend Est. -
P/FCF -
EPS past 5Y 36.15%
ROI -0.92%
52W High -1.02%
Beta 0.56
Dividend TTM -
Quick Ratio 8.98
Sales past 5Y 541.82%
Gross Margin 72.46%
52W Low 44.93%
ATR (14) 0.49
Dividend Ex-Date -
Current Ratio 10.73
EPS Y/Y TTM 90.17%
Oper. Margin -1.29%
RSI (14) 64.70
Volatility 0.48% 0.75%
Employees 797
Debt/Eq 0.04
Sales Y/Y TTM 33.86%
Profit Margin -1.66%
Recom 2.85
Target Price 71.40
Option/Short Yes / Yes
LT Debt/Eq 0.04
EPS Q/Q 908.33%
Payout -
Rel Volume 0.52
Prev Close 68.90
Sales Surprise 2.24%
EPS Surprise 101.55%
Sales Q/Q 27.72%
Earnings Feb 28 AMC
Avg Volume 1.33M
Price 68.97
SMA20 1.37%
SMA50 1.37%
SMA200 16.67%
Trades
Volume 698,660
Change 0.10%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-09-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Jul-19-23 Initiated
Robert W. Baird
Outperform
$69
Jul-13-23 Initiated
KeyBanc Capital Markets
Overweight
$70
May-23-23 Initiated
CL King
Buy
$75
Apr-14-23 Initiated
Mizuho
Buy
$75
Mar-24-23 Upgrade
Needham
Hold → Buy
$71
Oct-21-22 Initiated
RBC Capital Mkts
Outperform
$85
Oct-12-22 Initiated
Jefferies
Hold
$75
Oct-10-22 Downgrade
Needham
Buy → Hold
Apr-06-22 Initiated
Wolfe Research
Outperform
$69
Mar-02-22 Resumed
BofA Securities
Buy
$70
Jul-12-21 Initiated
Barclays
Overweight
$74
Jun-28-21 Reiterated
Needham
Buy
$72 → $78
Nov-05-20 Reiterated
Needham
Buy
$57 → $62
Oct-23-20 Initiated
Guggenheim
Buy
$77
Sep-02-20 Initiated
Robert W. Baird
Outperform
$52
Aug-07-20 Reiterated
Needham
Buy
$48 → $57
Jan-08-20 Initiated
SunTrust
Buy
$38
Nov-01-19 Initiated
Piper Jaffray
Overweight
$39
Oct-21-19 Initiated
Barclays
Overweight
$43
Show Previous Ratings
Mar-22-24 04:01PM
Mar-21-24 04:54PM
Mar-15-24 08:53AM
Mar-14-24 06:00AM
Feb-29-24 04:01PM
07:01PM
Loading…
Feb-28-24 07:01PM
05:40PM
04:41PM
(Associated Press Finance)
04:01PM
Feb-02-24 09:09PM
Jan-31-24 06:30AM
Jan-29-24 11:02PM
Jan-25-24 08:07AM
Jan-23-24 02:45PM
Jan-10-24 03:07PM
07:38PM
Loading…
Jan-08-24 07:38PM
11:28AM
07:58AM
(The Wall Street Journal)
07:00AM
07:00AM
07:00AM
Dec-27-23 04:01PM
Nov-20-23 09:55AM
Nov-06-23 12:00PM
Nov-01-23 06:00AM
Oct-31-23 09:27AM
Oct-30-23 05:55PM
05:40PM
04:28PM
(Associated Press Finance)
04:01PM
10:02AM
Loading…
Oct-26-23 10:02AM
Oct-23-23 10:00AM
Oct-16-23 10:23AM
Oct-14-23 01:15PM
Oct-11-23 11:42AM
Oct-02-23 06:00AM
Sep-22-23 11:47AM
Sep-11-23 11:47AM
Aug-25-23 06:00AM
Aug-21-23 06:00AM
Jul-28-23 12:46PM
Jul-27-23 05:25PM
04:18PM
04:01PM
Jun-29-23 06:00AM
May-31-23 10:27AM
May-25-23 09:28AM
May-16-23 02:45AM
May-08-23 09:06AM
May-01-23 05:15PM
04:07PM
04:01PM
Apr-25-23 06:00AM
Apr-24-23 06:00AM
Apr-17-23 03:54PM
Apr-10-23 06:00AM
Mar-29-23 06:00AM
Mar-07-23 06:00AM
Mar-04-23 07:39AM
Mar-01-23 05:25PM
04:01PM
Feb-25-23 02:14PM
Feb-22-23 10:00AM
Feb-08-23 04:30PM
Jan-31-23 06:00AM
Jan-19-23 06:43AM
Jan-12-23 09:19AM
07:21AM
Jan-11-23 06:00AM
Dec-23-22 12:58PM
Dec-22-22 09:03AM
Dec-21-22 06:00AM
Dec-19-22 09:40AM
Dec-13-22 12:40PM
06:00AM
Dec-02-22 09:40AM
07:10AM
Nov-18-22 06:00AM
Nov-16-22 11:06AM
09:40AM
Nov-07-22 12:52PM
Nov-01-22 12:35PM
Oct-31-22 05:15PM
04:01PM
09:40AM
Oct-24-22 10:00AM
Oct-13-22 09:40AM
Oct-09-22 10:20AM
Sep-26-22 09:40AM
Sep-12-22 09:15AM
Sep-08-22 06:00AM
Sep-07-22 09:40AM
Aug-22-22 09:40AM
Aug-18-22 06:00AM
Aug-17-22 06:00AM
Aug-08-22 12:00PM
Aug-05-22 04:34PM
Aug-04-22 09:40AM
Aug-02-22 11:13PM
04:11PM
Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Noblett Karen Chief Medical Officer Jan 31 '24 Option Exercise 0.00 27,500 0 45,716 Feb 02 05:59 PM Sama Rinda Chief Operating Officer Jan 31 '24 Option Exercise 0.00 28,000 0 83,854 Feb 02 06:00 PM Woock John EVP, Chief Mktg/Strtgy Officer Jan 31 '24 Option Exercise 0.00 28,000 0 93,302 Feb 02 05:59 PM Ford Alfred J Jr Chief Commercial Officer Jan 31 '24 Option Exercise 0.00 25,500 0 60,065 Feb 02 05:59 PM COHEN RAYMOND W Chief Executive Officer Jan 31 '24 Option Exercise 0.00 63,400 0 223,996 Feb 02 05:59 PM Keese Kari Leigh Chief Financial Officer Jan 31 '24 Option Exercise 0.00 6,167 0 46,812 Feb 02 05:59 PM COHEN RAYMOND W Chief Executive Officer Jan 31 '24 Sale 67.74 35,161 2,381,662 188,835 Feb 02 05:59 PM Ford Alfred J Jr Chief Commercial Officer Jan 31 '24 Sale 67.74 16,615 1,125,432 43,450 Feb 02 05:59 PM Woock John EVP, Chief Mktg/Strtgy Officer Jan 31 '24 Sale 67.74 15,899 1,076,933 77,403 Feb 02 05:59 PM Noblett Karen Chief Medical Officer Jan 31 '24 Sale 67.74 11,288 764,603 34,428 Feb 02 05:59 PM Keese Kari Leigh Chief Financial Officer Jan 31 '24 Sale 67.74 3,489 236,331 43,323 Feb 02 05:59 PM Noblett Karen Chief Medical Officer Jan 08 '24 Sale 69.00 15,999 1,103,961 18,216 Jan 10 08:00 PM Noblett Karen Chief Medical Officer Dec 28 '23 Sale 63.28 7,051 446,177 34,215 Dec 28 07:17 PM Noblett Karen Chief Medical Officer Dec 26 '23 Sale 63.00 949 59,787 41,266 Dec 28 07:17 PM Dearen Danny L. President & CFO Sep 29 '23 Option Exercise 0.00 11,250 0 31,452 Oct 03 07:37 PM Dearen Danny L. President & CFO Sep 29 '23 Sale 56.87 7,675 436,490 23,777 Oct 03 07:37 PM Ford Alfred J Jr Chief Commercial Officer Aug 15 '23 Sale 62.34 14,769 920,671 34,565 Aug 17 07:47 PM Ford Alfred J Jr Chief Commercial Officer Jul 28 '23 Sale 62.01 1,500 93,021 49,334 Aug 01 08:01 PM Dearen Danny L. President & CFO May 26 '23 Sale 49.46 7,999 395,646 9,202 May 31 08:01 PM Dearen Danny L. President & CFO Apr 21 '23 Option Exercise 14.19 13,208 187,422 37,201 Apr 25 08:06 PM Dearen Danny L. President & CFO Apr 21 '23 Sale 60.21 20,000 1,204,137 17,201 Apr 25 08:06 PM Dearen Danny L. President & CFO Apr 20 '23 Option Exercise 14.19 2,001 28,394 25,994 Apr 24 08:35 PM Dearen Danny L. President & CFO Apr 20 '23 Sale 60.01 2,001 120,073 23,993 Apr 24 08:35 PM Dearen Danny L. President & CFO Mar 31 '23 Option Exercise 16.00 15,000 240,031 38,993 Apr 04 08:24 PM Dearen Danny L. President & CFO Mar 31 '23 Sale 55.27 15,000 829,103 23,993 Apr 04 08:24 PM
Index RUT
P/E -
EPS (ttm) -1.52
Insider Own 4.62%
Shs Outstand 45.17M
Perf Week 1.59%
Market Cap 840.31M
Forward P/E -
EPS next Y -0.60
Insider Trans 59.31%
Shs Float 43.21M
Perf Month 8.48%
Income -66.43M
PEG -
EPS next Q -0.34
Inst Own 100.68%
Short Float 7.02%
Perf Quarter 10.02%
Sales 143.27M
P/S 5.87
EPS this Y 33.82%
Inst Trans 5.04%
Short Ratio 7.36
Perf Half Y 32.03%
Book/sh 7.48
P/B 2.48
EPS next Y 40.36%
ROA -15.40%
Short Interest 3.03M
Perf Year -9.91%
Cash/sh 1.14
P/C 16.24
EPS next 5Y 10.00%
ROE -18.93%
52W Range 8.92 - 24.50
Perf YTD 14.15%
Dividend Est. -
P/FCF -
EPS past 5Y 0.51%
ROI -17.94%
52W High -24.29%
Beta 1.67
Dividend TTM -
Quick Ratio 1.83
Sales past 5Y 57.29%
Gross Margin 29.02%
52W Low 107.96%
ATR (14) 0.90
Dividend Ex-Date -
Current Ratio 2.86
EPS Y/Y TTM 53.47%
Oper. Margin -40.16%
RSI (14) 57.95
Volatility 4.08% 6.28%
Employees 414
Debt/Eq 0.13
Sales Y/Y TTM -11.43%
Profit Margin -46.37%
Recom 1.29
Target Price 23.00
Option/Short Yes / Yes
LT Debt/Eq 0.10
EPS Q/Q 74.02%
Payout -
Rel Volume 1.26
Prev Close 18.46
Sales Surprise -2.00%
EPS Surprise 12.20%
Sales Q/Q -26.04%
Earnings Feb 29 AMC
Avg Volume 412.28K
Price 18.55
SMA20 5.16%
SMA50 5.16%
SMA200 17.05%
Trades
Volume 519,488
Change 0.49%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-11-23 Initiated
Craig Hallum
Buy
$29
Apr-25-22 Upgrade
Oppenheimer
Perform → Outperform
$28
Oct-19-21 Initiated
B. Riley Securities
Buy
$61
Oct-15-21 Resumed
Cowen
Outperform
$64
May-14-21 Downgrade
The Benchmark Company
Buy → Hold
Mar-23-21 Upgrade
The Benchmark Company
Hold → Buy
$54
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$40
Sep-22-20 Downgrade
Oppenheimer
Outperform → Perform
Sep-18-20 Initiated
Cowen
Outperform
$33
Aug-11-20 Downgrade
The Benchmark Company
Buy → Hold
Jul-08-20 Reiterated
Maxim Group
Buy
$18 → $26
Feb-24-20 Initiated
Lake Street
Buy
$25
Feb-19-20 Initiated
The Benchmark Company
Buy
$24
Feb-06-20 Resumed
B. Riley FBR
Buy
$27
Jan-08-20 Initiated
Stephens
Overweight
$23
Nov-21-19 Initiated
Oppenheimer
Outperform
$22
Jul-22-19 Initiated
H.C. Wainwright
Buy
$23
Nov-10-17 Reiterated
Maxim Group
Buy
$7 → $8
Sep-19-17 Reiterated
Maxim Group
Buy
$6 → $7
Jul-05-17 Upgrade
Janney
Neutral → Buy
$5
Show Previous Ratings
Mar-27-24 04:37PM
Mar-14-24 02:15AM
Mar-13-24 01:50AM
Mar-04-24 08:03AM
Mar-02-24 08:16AM
06:02AM
Loading…
Mar-01-24 06:02AM
(Thomson Reuters StreetEvents) +6.33%
Feb-29-24 04:03PM
Feb-20-24 08:03AM
Jan-08-24 08:15AM
Nov-16-23 02:54AM
Nov-10-23 02:33PM
Nov-09-23 04:04PM
Nov-02-23 04:03PM
12:27AM
Oct-19-23 05:04PM
04:24AM
Loading…
Oct-09-23 04:24AM
Sep-13-23 07:47AM
Aug-11-23 04:06PM
06:05AM
Aug-09-23 01:38PM
Aug-08-23 06:30PM
04:03PM
Jul-27-23 04:03PM
Jul-26-23 01:30PM
Jun-21-23 08:00PM
Jun-14-23 08:03AM
Jun-06-23 08:03AM
May-12-23 07:45AM
May-11-23 07:34AM
(Thomson Reuters StreetEvents)
May-10-23 05:35PM
04:03PM
Loading…
04:03PM
May-02-23 04:03PM
Apr-26-23 08:00PM
Mar-20-23 10:46PM
Mar-17-23 08:39AM
(Thomson Reuters StreetEvents) +7.71%
Mar-16-23 04:03PM
Mar-13-23 09:40AM
Mar-10-23 03:38PM
Mar-09-23 04:03PM
Mar-01-23 08:03AM
Feb-17-23 09:40AM
Jan-26-23 08:00AM
Jan-17-23 08:04AM
Jan-10-23 08:05AM
Jan-09-23 08:05AM
Jan-06-23 07:31AM
Jan-03-23 06:26AM
Dec-19-22 08:03AM
Dec-18-22 04:43PM
Dec-10-22 07:12AM
Nov-21-22 08:05AM
Nov-17-22 08:05AM
Nov-11-22 05:27AM
Nov-09-22 06:05PM
04:05PM
Nov-03-22 08:52AM
Oct-11-22 10:10AM
Oct-03-22 08:03AM
Aug-25-22 08:03AM
Aug-09-22 06:35PM
04:07PM
Aug-02-22 04:05PM
Jul-18-22 06:20AM
Jun-09-22 08:05AM
Jun-02-22 12:34PM
May-09-22 05:45PM
04:03PM
May-05-22 05:15PM
May-02-22 07:28PM
07:47AM
Apr-26-22 11:18AM
Apr-07-22 04:45PM
Mar-31-22 06:44AM
Mar-18-22 05:43PM
Mar-17-22 08:05AM
Mar-15-22 08:05AM
Mar-01-22 08:05AM
Feb-28-22 06:15PM
04:03PM
Feb-21-22 08:03AM
Feb-11-22 11:40AM
Feb-02-22 05:16AM
Feb-01-22 05:38PM
Jan-27-22 05:38PM
Jan-10-22 08:00AM
Jan-04-22 08:06AM
Dec-16-21 10:15AM
08:03AM
Dec-10-21 10:15AM
Dec-09-21 09:15AM
Nov-19-21 11:50AM
Nov-18-21 10:31AM
Nov-17-21 01:08PM
Nov-15-21 08:05AM
Nov-11-21 07:30PM
04:05PM
Nov-05-21 11:52AM
Nov-04-21 04:05PM
08:03AM
07:34AM
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Wichterman Troy Chief Financial Officer Mar 21 '24 Sale 17.83 520 9,272 127,614 Mar 25 05:03 PM DuRoss Amy Director Mar 13 '24 Sale 17.00 5,065 86,105 29,443 Mar 13 06:37 PM Wichterman Troy Chief Financial Officer Mar 12 '24 Sale 16.60 7,249 120,333 128,134 Mar 12 09:43 PM DE GREEF RODERICK President and CEO Mar 12 '24 Sale 16.60 7,249 120,333 461,854 Mar 12 09:43 PM Berard Todd Chief Marketing Officer Mar 12 '24 Sale 16.60 7,107 117,976 140,159 Mar 12 09:44 PM Mathew Aby J. EVP & Chief Scientific Officer Mar 12 '24 Sale 16.60 6,521 108,249 320,136 Mar 12 09:44 PM DuRoss Amy Director Mar 12 '24 Sale 16.86 6,135 103,436 34,508 Mar 13 06:37 PM Foster Karen A. Chief Quality and Operations Mar 12 '24 Sale 16.60 5,177 85,938 159,540 Mar 12 09:43 PM Aebersold Sarah Chief Human Resources Officer Mar 12 '24 Sale 16.60 4,361 72,393 69,843 Mar 12 09:42 PM Phillips Geraint SVP, Global Operations Mar 12 '24 Sale 16.60 3,598 59,727 65,998 Mar 12 09:44 PM Berard Todd Chief Marketing Officer Mar 11 '24 Sale 17.42 401 6,985 147,266 Mar 12 09:44 PM Wichterman Troy Chief Financial Officer Mar 11 '24 Sale 17.42 361 6,289 135,383 Mar 12 09:43 PM Foster Karen A. Chief Quality and Operations Mar 11 '24 Sale 17.42 319 5,557 164,717 Mar 12 09:43 PM Mathew Aby J. EVP & Chief Scientific Officer Mar 11 '24 Sale 17.42 313 5,452 326,657 Mar 12 09:44 PM Aebersold Sarah Chief Human Resources Officer Mar 11 '24 Sale 17.42 269 4,686 74,204 Mar 12 09:42 PM Phillips Geraint SVP, Global Operations Mar 11 '24 Sale 17.42 206 3,589 69,596 Mar 12 09:44 PM Phillips Geraint SVP, Global Operations Feb 21 '24 Sale 17.35 131 2,273 58,120 Feb 23 05:51 PM Berard Todd Chief Marketing Officer Feb 21 '24 Sale 17.35 111 1,926 115,688 Feb 23 05:51 PM Mathew Aby J. EVP & Chief Scientific Officer Feb 21 '24 Sale 17.35 101 1,752 275,214 Feb 23 05:51 PM Wichterman Troy Chief Financial Officer Feb 21 '24 Sale 17.35 97 1,683 64,823 Feb 23 05:51 PM Foster Karen A. Chief Quality and Operations Feb 21 '24 Sale 17.35 87 1,509 123,940 Feb 23 05:50 PM Aebersold Sarah Chief Human Resources Officer Feb 21 '24 Sale 17.35 58 1,006 41,806 Feb 23 05:52 PM Aebersold Sarah Chief Human Resources Officer Jan 23 '24 Sale 17.11 336 5,749 41,864 Jan 25 05:10 PM DE GREEF RODERICK President and CEO Jan 19 '24 Sale 16.76 2,642 44,280 439,897 Jan 23 05:29 PM Wichterman Troy Chief Financial Officer Jan 19 '24 Sale 16.76 2,419 40,542 64,920 Jan 23 05:29 PM Phillips Geraint SVP, Global Operations Jan 19 '24 Sale 16.76 1,776 29,766 58,251 Jan 23 05:30 PM Mathew Aby J. EVP & Chief Scientific Officer Jan 19 '24 Sale 16.76 1,450 24,302 275,315 Jan 23 05:30 PM Berard Todd Chief Marketing Officer Jan 19 '24 Sale 16.76 1,232 20,648 115,799 Jan 23 05:29 PM Foster Karen A. Chief Quality and Operations Jan 19 '24 Sale 16.76 1,198 20,078 124,027 Jan 23 05:30 PM Aebersold Sarah Chief Human Resources Officer Jan 19 '24 Sale 16.76 862 14,447 42,200 Jan 23 05:29 PM Mathew Aby J. EVP & Chief Scientific Officer Jan 02 '24 Sale 16.75 697 11,675 276,765 Jan 04 05:03 PM Foster Karen A. Chief Quality and Operations Jan 02 '24 Sale 16.75 601 10,067 125,225 Jan 04 05:04 PM Berard Todd Chief Marketing Officer Jan 02 '24 Sale 16.75 491 8,224 117,031 Jan 04 05:04 PM Wichterman Troy Chief Financial Officer Dec 22 '23 Sale 16.79 314 5,272 67,339 Dec 28 04:46 PM Wichterman Troy Chief Financial Officer Dec 01 '23 Sale 12.37 666 8,238 67,112 Dec 04 07:14 PM Mathew Aby J. EVP & Chief Scientific Officer Dec 01 '23 Sale 12.37 591 7,311 275,961 Dec 04 07:15 PM Foster Karen A. Chief Quality Officer Dec 01 '23 Sale 12.37 466 5,764 125,340 Dec 04 07:15 PM Berard Todd Chief Marketing Officer Dec 01 '23 Sale 12.37 394 4,874 117,522 Dec 04 07:14 PM Aebersold Sarah Chief Human Resources Officer Dec 01 '23 Sale 12.37 394 4,874 43,062 Dec 04 07:15 PM Phillips Geraint SVP, Global Operations Dec 01 '23 Sale 12.37 303 3,748 59,587 Dec 04 07:14 PM Mathew Aby J. EVP & Chief Scientific Officer Nov 13 '23 Sale 10.77 132 1,422 275,726 Nov 15 10:41 AM Foster Karen A. Chief Quality Officer Nov 13 '23 Sale 10.77 114 1,228 125,539 Nov 15 10:41 AM Phillips Geraint SVP, Global Operations Nov 13 '23 Sale 10.66 111 1,183 59,656 Nov 15 10:41 AM Berard Todd Chief Marketing Officer Nov 13 '23 Sale 10.77 98 1,055 117,916 Nov 15 10:41 AM Wichterman Troy Chief Financial Officer Nov 13 '23 Sale 10.66 97 1,034 67,480 Nov 15 10:40 AM Aebersold Sarah Chief Human Resources Officer Nov 13 '23 Sale 10.77 76 819 43,456 Nov 15 10:41 AM Rice Michael Former CEO and Director Oct 30 '23 Sale 9.13 72,603 662,865 347,085 Nov 01 05:30 PM Casdin Partners Master Fund, L 10% Owner Oct 19 '23 Buy 11.19 927,165 10,374,976 8,557,165 Oct 23 05:42 PM Rice Michael Chief Executive Officer Sep 28 '23 Sale 14.16 831 11,767 418,635 Oct 02 05:07 PM Mathew Aby J. EVP & Chief Scientific Officer Sep 28 '23 Sale 14.16 659 9,331 273,121 Oct 02 05:04 PM Foster Karen A. Chief Quality Officer Sep 28 '23 Sale 14.16 568 8,043 124,767 Oct 02 05:08 PM Berard Todd Chief Marketing Officer Sep 28 '23 Sale 14.16 464 6,570 118,014 Oct 02 04:56 PM Wichterman Troy Chief Financial Officer Sep 21 '23 Sale 12.70 539 6,845 66,300 Sep 25 04:57 PM Rice Michael Chief Executive Officer Aug 25 '23 Sale 10.99 1,729 19,002 416,906 Aug 29 05:53 PM Wichterman Troy Chief Financial Officer Aug 25 '23 Sale 10.99 585 6,429 65,933 Aug 29 05:51 PM Mathew Aby J. EVP & Chief Scientific Officer Aug 25 '23 Sale 10.99 519 5,704 271,220 Aug 29 05:53 PM Foster Karen A. Chief Quality Officer Aug 25 '23 Sale 10.99 410 4,506 124,342 Aug 29 05:52 PM Aebersold Sarah Chief Human Resources Officer Aug 25 '23 Sale 10.99 347 3,814 43,532 Aug 29 05:48 PM Schulz Marcus Chief Revenue Officer Aug 25 '23 Sale 10.99 347 3,814 42,097 Aug 29 05:54 PM Berard Todd Chief Marketing Officer Aug 25 '23 Sale 10.99 347 3,814 118,478 Aug 29 05:50 PM Phillips Geraint SVP, Global Operations Aug 25 '23 Sale 10.99 179 1,967 58,045 Aug 29 05:49 PM Rice Michael Chief Executive Officer Aug 14 '23 Sale 12.38 277 3,429 418,635 Aug 16 04:49 PM Mathew Aby J. EVP & Chief Scientific Officer Aug 14 '23 Sale 12.38 180 2,228 271,739 Aug 16 04:48 PM Foster Karen A. Chief Quality Officer Aug 14 '23 Sale 12.38 156 1,931 124,752 Aug 16 04:46 PM Berard Todd Chief Marketing Officer Aug 14 '23 Sale 12.38 134 1,659 118,825 Aug 16 04:48 PM Phillips Geraint SVP, Global Operations Aug 14 '23 Sale 12.57 109 1,370 58,224 Aug 16 04:47 PM Schulz Marcus Chief Revenue Officer Aug 14 '23 Sale 12.38 108 1,337 42,444 Aug 16 04:49 PM Aebersold Sarah Chief Human Resources Officer Aug 14 '23 Sale 12.38 104 1,288 43,879 Aug 16 04:46 PM Wichterman Troy Chief Financial Officer Aug 14 '23 Sale 12.57 94 1,182 66,518 Aug 16 04:47 PM Casdin Partners Master Fund, L 10% Owner Aug 09 '23 Buy 13.20 58,465 771,744 7,630,000 Aug 11 05:01 PM Schulz Marcus Chief Revenue Officer Jul 24 '23 Sale 19.50 679 13,240 42,552 Jul 26 06:09 PM Aebersold Sarah Chief Human Resources Officer Jul 24 '23 Sale 19.50 462 9,009 43,983 Jul 26 06:08 PM Mathew Aby J. EVP & Chief Scientific Officer Jul 20 '23 Option Exercise 2.06 10,000 20,600 281,919 Jul 24 04:35 PM Mathew Aby J. EVP & Chief Scientific Officer Jul 20 '23 Sale 20.07 10,000 200,700 271,919 Jul 24 04:35 PM Mathew Aby J. EVP & Chief Scientific Officer Jul 19 '23 Option Exercise 2.06 10,000 20,600 281,919 Jul 24 04:35 PM Mathew Aby J. EVP & Chief Scientific Officer Jul 19 '23 Sale 20.46 10,000 204,600 271,919 Jul 24 04:35 PM Schulz Marcus Chief Revenue Officer Jul 11 '23 Sale 22.79 331 7,543 43,231 Jul 13 05:10 PM Rice Michael Chief Executive Officer Jun 27 '23 Sale 22.91 877 20,092 418,912 Jun 29 04:40 PM Mathew Aby J. EVP & Chief Scientific Officer Jun 27 '23 Sale 22.91 695 15,922 271,919 Jun 29 04:38 PM Foster Karen A. Chief Quality Officer Jun 27 '23 Sale 22.91 590 13,517 124,908 Jun 29 04:37 PM Berard Todd Chief Marketing Officer Jun 27 '23 Sale 22.91 489 11,203 118,959 Jun 29 04:35 PM Mathew Aby J. EVP & Chief Scientific Officer Jun 22 '23 Option Exercise 2.06 10,000 20,600 282,614 Jun 23 04:58 PM Mathew Aby J. EVP & Chief Scientific Officer Jun 22 '23 Sale 23.32 10,000 233,200 272,614 Jun 23 04:58 PM Wichterman Troy Chief Financial Officer Jun 22 '23 Sale 23.41 541 12,665 66,612 Jun 26 04:36 PM Mathew Aby J. EVP & Chief Scientific Officer Jun 21 '23 Option Exercise 2.06 10,000 20,600 282,614 Jun 23 04:58 PM Mathew Aby J. EVP & Chief Scientific Officer Jun 21 '23 Sale 22.97 10,000 229,700 272,614 Jun 23 04:58 PM Rice Michael CEO May 31 '23 Sale 23.21 1,679 38,970 419,789 Jun 02 08:00 PM Wichterman Troy Chief Financial Officer May 31 '23 Sale 23.21 560 12,998 67,153 Jun 02 08:01 PM Mathew Aby J. EVP & Chief Scientific Officer May 31 '23 Sale 23.21 504 11,698 272,614 Jun 02 08:02 PM Foster Karen A. Chief Quality Officer May 31 '23 Sale 23.21 392 9,098 125,498 Jun 02 08:00 PM Schulz Marcus Chief Revenue Officer May 31 '23 Sale 23.21 337 7,822 43,562 Jun 02 08:01 PM Berard Todd Chief Marketing Officer May 31 '23 Sale 23.21 337 7,822 119,448 Jun 02 08:01 PM Aebersold Sarah Chief Human Resources Officer May 31 '23 Sale 23.21 337 7,822 44,445 Jun 02 08:00 PM Phillips Geraint SVP, Global Operations May 31 '23 Sale 23.21 174 4,039 58,333 Jun 23 07:30 PM Mathew Aby J. EVP & Chief Scientific Officer May 25 '23 Option Exercise 2.06 10,000 20,600 283,118 May 25 08:18 PM Mathew Aby J. EVP & Chief Scientific Officer May 25 '23 Sale 22.33 10,000 223,300 273,118 May 25 08:18 PM Mathew Aby J. EVP & Chief Scientific Officer May 24 '23 Option Exercise 2.06 10,000 20,600 283,118 May 25 08:18 PM Mathew Aby J. EVP & Chief Scientific Officer May 24 '23 Sale 22.14 10,000 221,400 273,118 May 25 08:18 PM Casdin Partners Master Fund, L 10% Owner May 22 '23 Buy 21.86 24,973 545,790 150,000 May 23 05:46 PM Casdin Partners Master Fund, L 10% Owner May 19 '23 Buy 22.55 50,000 1,127,430 125,027 May 23 05:46 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite